Evidence map›Paper›PMID 22751534›Full record

ArticleAntimicrobial agents and chemotherapy2012

Antibacterial properties of an oligo-acyl-lysyl hexamer targeting Gram-negative species.

Fadia Zaknoon, Keren Goldberg, Hadar Sarig, Raquel F Epand, Richard M Epand, Amram Mor

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Fadia ZaknoonDepartment of Biotechnology & Food Engineering, Technion-Israel Institute of Technology, Haifa, Israel.
Keren Goldberg
Hadar Sarig
Raquel F Epand
Richard M Epand
Amram Mor
Technion – Israel Institute of Technology · ILMcMaster University · CA

Funding

Canadian Institutes of Health Research MOP 86608
6 · The paper itself

Abstract

Toward developing new tools for fighting resistance to antibiotics, we investigated the antibacterial properties of a new decanoyl-based oligo-acyl-lysyl (OAK) hexamer, aminododecanoyl-lysyl-[aminodecanoyl-lysyl](5) (α(12)-5α(10)). The OAK exhibited preferential activity against Gram-negative bacteria (GNB), as determined using 36 strains, including diverse species, with an MIC(90) of 6.2 μM. The OAK's bactericidal mode of action was associated with rapid membrane depolarization and cell permeabilization, suggesting that the inner membrane was the primary target, whereas the observed binding affinity to lipoteichoic acid suggested that inefficacy against Gram-positive species resulted from a cell wall interaction preventing α(12)-5α(10) from reaching internal targets. Interestingly, perturbation of the inner membrane structure and function was preserved at sub-MIC values. This prompted us to assess the OAK's effect on the proton motive force-dependent efflux pump AcrAB-TolC, implicated in the low sensitivity of GNB to various antibiotics, including erythromycin. We found that under sub-MIC conditions, wild-type Escherichia coli was significantly more sensitive to erythromycin (the MIC dropped by >10-fold), unlike its acr-deletion mutant. Collectively, the data suggest a useful approach for treating GNB infections through overcoming antibiotic efflux.

Indexed as

Anti-Bacterial AgentsAntimicrobial Cationic PeptidesBacterial ProteinsCarrier ProteinsCell Membrane PermeabilityDrug Resistance, BacterialErythromycinGram-Negative BacteriaGram-Positive BacteriaLipopolysaccharidesMicrobial Sensitivity TestsMutationOligopeptidesSpecies SpecificityTeichoic AcidsAcrAB-TolC protein, Salmonella entericaAnti-Bacterial AgentsAntimicrobial Cationic PeptidesBacterial ProteinsCarrier ProteinsErythromycinLipopolysaccharideslipoteichoic acidOligopeptidesTeichoic Acids

Identifiers

PMID22751534
PMCPMC3421859
OpenAlexW2137827489

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.